Duke Early Phase Clinical Research

Duke Early Phase Clinical Research


Duke Early Phase Clinical Research is one of just a handful of state-of-the-art hospital-based early phase research units in the country. The Early Phase Unit enables Duke investigators to conduct proof-of-concept research, including efforts to identify and validate novel biomarkers, while leveraging advances at the forefront of technology. In addition to early-stage investigator-initiated studies and NIH-funded research, Duke researchers also work with pharmaceutical, biotechnology, and medical device companies to generate data.

Building on the strength of Duke's thought leadership, therapeutic expertise, patient base, and access to the latest technologies, Duke Early Phase Clinical Research is a critical component of the Duke Clinical Research Institute’s efforts to translate new laboratory discoveries into treatments for patients.

Leadership

Michael Cohen-Wolkowiez
Michael Cohen-Wolkowiez
Faculty Director, Duke Early Phase Clinical Research
Donna Hamel landscape
Donna Hamel
Director of Operations, Duke Early Phase Clinical Research